| 000 | 01494 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512232713.0 | ||
| 264 | 0 | _c19810623 | |
| 008 | 198106s 0 0 eng d | ||
| 022 | _a0020-9996 | ||
| 024 | 7 |
_a10.1097/00004424-198103000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeoh, S H | |
| 245 | 0 | 0 |
_aThe in vitro activation of complement by radiologic contrast materials and its inhibition with epsilon-aminocaproic acid. _h[electronic resource] |
| 260 |
_bInvestigative radiology _c |
||
| 300 |
_a152-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAminocaproates _xpharmacology |
| 650 | 0 | 4 |
_aAminocaproic Acid _xpharmacology |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aContrast Media _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEdetic Acid _xpharmacology |
| 650 | 0 | 4 |
_aEgtazic Acid _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIodipamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMeglumine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPlasminogen Activators _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPlasminogen Inactivators |
| 650 | 0 | 4 | _aTemperature |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSage, M R | |
| 700 | 1 | _aWillis, R B | |
| 700 | 1 | _aRoberts-Thomson, P | |
| 700 | 1 | _aBradley, J | |
| 773 | 0 |
_tInvestigative radiology _gvol. 16 _gno. 2 _gp. 152-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004424-198103000-00014 _zAvailable from publisher's website |
| 999 |
_c6783351 _d6783351 |
||